Stocks Trending Alert: Stereotaxis Inc (NASDAQ:STXS), Antares Pharma Inc (NASDAQ:ATRS), InterMune Inc (NASDAQ:ITMN), Ares Capital Corporation (NASDAQ:ARCC)

Lewes, DE -- (SBWire) -- 11/13/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Stereotaxis Inc (NASDAQ:STXS), Antares Pharma Inc (NASDAQ:ATRS), InterMune Inc (NASDAQ:ITMN), Ares Capital Corporation (NASDAQ:ARCC)

Stereotaxis Inc (NASDAQ:STXS) opened its shares at the price of $3.88 for the day. Its closing price was $4.04 after gaining +4.66% for the day. The company traded with the total volume of 1.23 million shares, while its average trading volume remained 2.06 million shares. The beta of STXS stands at2.33. Stereotaxis, Inc. designs, manufactures, and markets cardiology instrument control system in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system.

For How Long STXS will Fight for Profitability? Read This Trend Analysis report

Antares Pharma Inc (NASDAQ:ATRS) close at $3.74 with the total traded volume of 1.23 million shares, and average volume of 2.52 million. The 52 week range of the stock remained $1.23 - $2.52, while its day lowest price was $3.60 and it hit its day highest price at $3.75. Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide.

Can Investors Bet on ATRS after this News update? Find out in this Research Report

InterMune Inc (NASDAQ:ITMN) started its trading session with the price of $12.63 and closed at $12.88 by scoring +1.66%. ITMN’s stocks traded with total volume of 1.22 million shares, while the average trading volume remained 1.27 million shares. The beta of ITMN stands at 2.80. Day range of the stock was $12.09 -$12.90. InterMune, Inc., a biotechnology company, engages in the research, development, and commercialization of therapies in pulmonology and orphan fibrotic diseases.

Will ITMN Continue To Move Higher? Find Out Here

Ares Capital Corporation (NASDAQ:ARCC) ended its day with the gain of +0.86% and closed at the price of $17.68 after opening at $17.58. Stock traded during its last trading session with the total volume of 1.21 million shares, as compared to its average volume of 1.34 million shares.

Why Should Investors Buy ARCC After The Recent Gain? Just Go Here and Find Out

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/

Media Relations Contact

News Department
http://leadingstockalerts.com/

View this press release online at: http://rwire.com/384033